Influence of a circadian-stage-dependent dosing schedule on the pharmacokinetics of isepamicin in humans

Journal of Infection and Chemotherapy

Volumn 2, Issue 2, 1996, Pages 106-109

  Yoshiyama, Yuji ^a,e   Kobayashi, Teruaki ^b   Ohdo, Shigehiro ^c   Ogawa, Nobuya ^d   Bergeron, Michel G ^e   Labrecque, Gaston ^e   Beauchamp, Denis ^e   Nakano, Shigeyuki ^f  

^a KEIO UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITÉ LAVAL   (Canada)

^f OITA UNIVERSITY   (Japan)

Author keywords

Chronopharmacokinetics; Human; Isepamicin

Indexed keywords

EID: 0007565101     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02350851     Document Type: Article

References (14)

1. Nakano S, Ogawa N. Chronotoxicity of gentamicin in mice. IRCS Med Sci 1982;10:592-593.
2. Elting L, Bodey GP, Rosenbaum B, Fainstein V. Circadian variation in serum amikacin levels. J Clin Pharmacol 1990;30:798-801.
3. Morne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;194:97-110.
4. Nakano S, Song J, Ogawa N. Chronopharmacokinetics of gentamicin: comparison between man and mice. Ann Rev Chronopharmacol 1990;7:277-280.
5. Yoshiyama Y, Kobayashi T, Tomonaga F, Nakano S. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J Antibiot 1992;45:806-808.
6. Yoshiyama Y, Nishikawa S, Sugiyama T, Kobayashi T, Shimada H, Tomonaga F, et al. Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats. Antimicrob Agents Chemother 1993;37:2042-2043.
7. Yoshiyama Y, Grenier L, Gourde P, Simard M, Lin L, Morin NJ, et al. Temporal variation in nephrotoxicity of low dose of isepamicin in rats. Antimicrob Agents Chemother 1996;40:802-806.
8. Kovarik JM, Hoepelman IM, Verhoef J. Once-daily aminoglycoside administration: new strategies for an old drug. Eur J Microbiol Infect Dis 1989;8:761-769.
9. Rankin LI, Luft FC, Yum MN, Sloan RS, Dinwiddie CB Jr, Isaacs LL. Comparative nephrotoxicity of SCH21420 and amikacin in rats. Antimicrob Agents Chemother 1979;16:491-494.
10. Mauracher EH, Lau W, Kartowisastro H, Ong K, Genato VX, Limson B, et al. Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries. Clin Ther 1989;11:604-613.
11. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-99.
12. Ohdo S, Nakano S, Ogawa N. An influencing factor to predict plasma valproate concentrations: circadian stage-dependent kinetics. Jpn J Clin Pharmacol Ther 1990; 21:747-754.
13. Reeves DS, Bywater MJ, Wise R, Whitmarsh VB. Availability of three antibiotics after intramuscular injection into thigh and buttock. Lancet 1974;2:1421-1422.
14. Verpooten GA, Giuliano RA, Verbist L, Eestermans G, DeBroe ME. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther 1989;45:22-27.